Qnovia

Qnovia, Inc. was founded by Mario Danek in 2018, focusing on the development and commercialization of proprietary inhalation device technology to improve patient outcomes. The company's drug delivery platform, RespiRx™, is the first orientation-independent portable vibrating mesh nebulizer that operates effectively in any position held by the patient. Qnovia sees significant opportunities in leveraging its drug delivery technology to enhance treatments for asthma, chronic obstructive pulmonary disease (COPD), vaccine delivery, pain management, as well as several generic drugs and selected investigational new drugs.